HUMALOG LISPRO: 435 Adverse Event Reports & Safety Profile
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
435
Total FAERS Reports
13 (3.0%)
Deaths Reported
227
Hospitalizations
435
As Primary/Secondary Suspect
13
Life-Threatening
20
Disabilities
First Report: 1990 · Latest Report: 20140616
What Are the Most Common HUMALOG LISPRO Side Effects?
#1 Most Reported
Blood glucose increased
172 reports (39.5%)
#2 Most Reported
Diabetic ketoacidosis
46 reports (10.6%)
#3 Most Reported
Blood glucose decreased
46 reports (10.6%)
All HUMALOG LISPRO Side Effects by Frequency
| Side Effect | Reports | % of Total | Deaths | Hosp. |
|---|---|---|---|---|
| Blood glucose increased | 172 | 39.5% | 3 | 96 |
| Blood glucose decreased | 46 | 10.6% | 0 | 22 |
| Diabetic ketoacidosis | 46 | 10.6% | 0 | 38 |
| Drug ineffective | 29 | 6.7% | 0 | 17 |
| Malaise | 28 | 6.4% | 1 | 10 |
| Hypoglycaemia | 25 | 5.8% | 0 | 16 |
| Fall | 23 | 5.3% | 1 | 16 |
| Blindness | 19 | 4.4% | 1 | 5 |
| Incorrect dose administered | 19 | 4.4% | 1 | 12 |
| Drug dose omission | 18 | 4.1% | 0 | 9 |
| Hypoglycaemic unconsciousness | 18 | 4.1% | 1 | 10 |
| Visual acuity reduced | 16 | 3.7% | 0 | 6 |
| Underdose | 15 | 3.5% | 0 | 8 |
| Cataract | 14 | 3.2% | 0 | 6 |
| Cerebrovascular accident | 14 | 3.2% | 1 | 9 |
| Glycosylated haemoglobin increased | 14 | 3.2% | 0 | 8 |
| Hyperglycaemia | 14 | 3.2% | 0 | 6 |
| Thirst | 14 | 3.2% | 0 | 9 |
| Myocardial infarction | 13 | 3.0% | 0 | 6 |
| Vomiting | 13 | 3.0% | 0 | 6 |
Who Reports HUMALOG LISPRO Side Effects? Age & Gender Data
Average age: 54.6 years. Most reports from: US. View detailed demographics →
Is HUMALOG LISPRO Getting Safer? Reports by Year
| Year | Reports | Deaths | Hosp. |
|---|---|---|---|
| 2000 | 3 | 0 | 1 |
| 2001 | 4 | 1 | 2 |
| 2002 | 1 | 0 | 1 |
| 2003 | 3 | 0 | 2 |
| 2004 | 2 | 0 | 1 |
| 2005 | 4 | 0 | 2 |
| 2006 | 1 | 0 | 0 |
| 2007 | 3 | 0 | 3 |
| 2008 | 7 | 0 | 4 |
| 2009 | 7 | 0 | 4 |
| 2010 | 7 | 0 | 4 |
| 2011 | 6 | 0 | 4 |
| 2012 | 16 | 0 | 9 |
| 2013 | 76 | 2 | 46 |
| 2014 | 110 | 0 | 67 |
What Is HUMALOG LISPRO Used For?
| Indication | Reports |
|---|---|
| Product used for unknown indication | 137 |
| Type 2 diabetes mellitus | 116 |
| Diabetes mellitus | 96 |
| Type 1 diabetes mellitus | 76 |
HUMALOG LISPRO vs Alternatives: Which Is Safer?
HUMALOG LISPRO vs HUMALOG LISPRO, NPL
HUMALOG LISPRO vs HUMAN C1-ESTERASE INHIBITOR
HUMALOG LISPRO vs HUMAN COAGULATION FACTOR VIII/VON WILLEBRAND FACTOR COMPLEX
HUMALOG LISPRO vs HUMAN CYTOMEGALOVIRUS IMMUNE GLOBULIN
HUMALOG LISPRO vs HUMAN HEPATITIS B VIRUS IMMUNE GLOBULIN
HUMALOG LISPRO vs HUMAN IMMUNOGLOBULIN G
HUMALOG LISPRO vs HUMAN IMMUNOGLOBULIN G\HYALURONIDASE
HUMALOG LISPRO vs HUMAN IMMUNOGLOBULIN G\HYALURONIDASE RECOMBINANT HUMAN
HUMALOG LISPRO vs HUMAN PAPILLOMAVIRUS QUADRIVALENT VACCINE, RECOMBINANT
HUMALOG LISPRO vs HUMAN RABIES VIRUS IMMUNE GLOBULIN
Official FDA Label for HUMALOG LISPRO
Official prescribing information from the FDA-approved drug label.